These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 1942334)
21. Role of proliferative activity estimated by bromodeoxyuridine labeling index in determining predictive factors of recurrence in superficial intermediately malignant bladder tumors. Tachibana M; Miyakawa A; Nakamura K; Baba S; Murai M; Tazaki H J Urol; 1996 Jul; 156(1):63-9. PubMed ID: 8648839 [TBL] [Abstract][Full Text] [Related]
22. DNA cytometric features in biopsies of TaT1 urothelial cell cancer predict recurrence and stage progression more accurately than stage, grade, or treatment modality. Baak JP; Bol MG; van Diermen B; Janssen EA; Buhr-Wildhagen SB; Mestad O; Øgreid P; Kjellevold KH Urology; 2003 Jun; 61(6):1266-72. PubMed ID: 12809927 [TBL] [Abstract][Full Text] [Related]
23. Prognostic factors for survival in patients with transitional cell carcinoma of the bladder: evaluation by histopathologic grade, pathologic stage and flow-cytometric analysis. Lee SE; Park MS Eur Urol; 1996; 29(2):193-8. PubMed ID: 8647146 [TBL] [Abstract][Full Text] [Related]
24. Proliferation indices as independent prognostic factors in papillary Ta-T1 transitional cell bladder tumours. Lipponen PK; Eskelinen MJ; Jauhiainen K; Terho R; Nordling S Br J Urol; 1993 Oct; 72(4):451-7. PubMed ID: 8261303 [TBL] [Abstract][Full Text] [Related]
25. Clinical significance of flow cytometric deoxyribonucleic acid measurements of deparaffinized specimens in bladder tumors. Miao T; Wang Z; Sang N; Xiong R; Cao S Eur Urol; 1992; 21(2):98-102. PubMed ID: 1499623 [TBL] [Abstract][Full Text] [Related]
26. Transitional cell carcinoma of the upper urinary tract: evaluation of prognostic factors by histopathology and flow cytometric analysis. Corrado F; Ferri C; Mannini D; Corrado G; Bertoni F; Bacchini P; Lelli G; Lieber MM; Song JM J Urol; 1991 Jun; 145(6):1159-63. PubMed ID: 2033684 [TBL] [Abstract][Full Text] [Related]
27. DNA ploidy as a prognostic factor in muscle invasive transitional cell carcinoma of the bladder. Deliveliotis C; Georgoulakis J; Skolarikos A; Trakas N; Varkarakis J; Albanis S; Protogerou B; Bamias A Urol Res; 2005 Feb; 33(1):39-43. PubMed ID: 15258707 [TBL] [Abstract][Full Text] [Related]
28. Flow cytometric DNA ploidy analysis in canine transitional cell carcinoma of urinary bladders. Clemo FA; DeNicola DB; Carlton WW; Morrison WB; Walker E Vet Pathol; 1994 Mar; 31(2):207-15. PubMed ID: 8203084 [TBL] [Abstract][Full Text] [Related]
29. A clinically applicable method to preserve urine and bladder washing cells for flow cytometric monitoring of bladder cancer patients. Deitch AD; Andreotti VA; Strand MA; Howell L; deVere White RW J Urol; 1990 Apr; 143(4):700-5. PubMed ID: 2179581 [TBL] [Abstract][Full Text] [Related]
30. Comparison of quantitative and classic prognosticators in urinary bladder carcinoma. A multivariate analysis of DNA flow cytometric, nuclear morphometric and clinicopathological features. Blomjous CE; Schipper NW; Vos W; Baak JP; de Voogt HJ; Meijer CJ Virchows Arch A Pathol Anat Histopathol; 1989; 415(5):421-8. PubMed ID: 2508302 [TBL] [Abstract][Full Text] [Related]
31. Prognostic role of flow cytometry in superficial bladder cancer. Di Silverio F; von Heland M; De Berardinis E; Izzi R; Buscarini M; De Vita R; Forte R; Seccareccia F; Menotti A Eur Urol; 1992; 21 Suppl 1():22-5. PubMed ID: 1425833 [TBL] [Abstract][Full Text] [Related]
32. Deoxyribonucleic acid ploidy enhances the cytological prediction of recurrent transitional cell carcinoma of the bladder. Slaton JW; Dinney CP; Veltri RW; Miller CM; Liebert M; O'Dowd GJ; Grossman HB J Urol; 1997 Sep; 158(3 Pt 1):806-11. PubMed ID: 9258087 [TBL] [Abstract][Full Text] [Related]